Skip to main content

Table 2 Clinical characteristics of the study population

From: A genetic variant in the promoter of lncRNA MALAT1 is related to susceptibility of ischemic stroke

Variables

Controls, n = 320

IS patients, n = 316

P value

Age, years (Mean Âħ SD)

60.72 Âħ 10.77

62.23 Âħ 11.36

0.087

Gender (M / F)

204 / 116

216 / 100

0.220

Hypertension (%)

59 (18.4%)

126 (39.9)

< 0.001

Diabetes mellitus (%)

30 (9.4%)

50 (15.8%)

< 0.001

Smoker (%)

50 (15.6%)

98 (31.0%)

< 0.001

TCH (mmol/L)

4.19 Âħ 0.79

4.64 Âħ 1.16

< 0.001

TG (mmol/L)

1.37 Âħ 0.99

1.81 Âħ 1.31

< 0.001

HDL-C (mmol/L)

1.50 Âħ 0.31

1.13 Âħ 0.32

< 0.001

LDL -C (mmol/L)

2.39 Âħ 0.66

2.92 Âħ 0.98

< 0.001

Apo-A1(g/L)

1.73 Âħ 1.10

1.23 Âħ 0.26

< 0.001

Apo-B (g/L)

0.77 Âħ 0.31

1.00 Âħ 0.31

< 0.001

NEFA (mmol/L)

0.71 Âħ 0.30

0.53 Âħ 0.28

< 0.001

  1. IS ischemic stroke, SD Standard deviation, M Male, F Female, TC Total cholesterol, TG Triglyceride, HDL-C High density lipoprotein-cholesterol, LDL-C Low density lipoprotein-cholesterol, Apo-A1 Apolipoprotein A1, Apo-B Apolipoprotein B, NEFA Non-esterified fatty acid